Nebula Research & Development LLC Buys Shares of 1,896 UFP Technologies, Inc. (NASDAQ:UFPT)

Nebula Research & Development LLC acquired a new stake in shares of UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,896 shares of the industrial products company's stock, valued at approximately $464,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UFPT. AlphaQuest LLC purchased a new stake in shares of UFP Technologies in the fourth quarter worth $25,000. Venturi Wealth Management LLC purchased a new stake in UFP Technologies in the 4th quarter worth $74,000. EverSource Wealth Advisors LLC raised its holdings in UFP Technologies by 24.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the industrial products company's stock valued at $81,000 after acquiring an additional 66 shares during the period. KBC Group NV lifted its position in shares of UFP Technologies by 37.9% in the fourth quarter. KBC Group NV now owns 375 shares of the industrial products company's stock valued at $92,000 after acquiring an additional 103 shares in the last quarter. Finally, Principal Securities Inc. boosted its stake in shares of UFP Technologies by 110.4% in the fourth quarter. Principal Securities Inc. now owns 444 shares of the industrial products company's stock worth $109,000 after acquiring an additional 233 shares during the period. 87.28% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on UFPT shares. StockNews.com downgraded UFP Technologies from a "hold" rating to a "sell" rating in a research note on Thursday, January 23rd. Raymond James started coverage on shares of UFP Technologies in a research report on Friday, March 28th. They set a "market perform" rating for the company.

UFP Technologies Price Performance

Shares of NASDAQ:UFPT traded up $2.08 during mid-day trading on Monday, reaching $204.29. The stock had a trading volume of 224,798 shares, compared to its average volume of 81,125. The business's 50 day moving average price is $209.15 and its 200 day moving average price is $252.77. UFP Technologies, Inc. has a 1 year low of $178.26 and a 1 year high of $366.41. The company has a market cap of $1.57 billion, a P/E ratio of 29.37 and a beta of 1.08. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.45. The business had revenue of $144.07 million for the quarter, compared to analysts' expectations of $141.67 million. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%.

Insider Transactions at UFP Technologies

In other news, Director Daniel C. Croteau sold 6,846 shares of the firm's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $228.41, for a total value of $1,563,694.86. Following the completion of the sale, the director now directly owns 1,785 shares of the company's stock, valued at $407,711.85. This trade represents a 79.32 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 6.17% of the company's stock.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.